Drug intelligence / Profile preview

Keltican Forte

Development stage
Unknown
Lead developer
DermaPharm
Modality
Small Molecules
Administration
Oral
01

Overview

Keltican Forte is an oral nutritional supplement and food for special medical purposes (FSMP) specifically designed to support the management and regeneration of peripheral nerve damage. Developed and manufactured by Trommsdorff (a subsidiary of Dermapharm), the formulation combines uridine monophosphate (UMP), vitamin B12, and folic acid. UMP acts as a critical nucleotide building block for the synthesis of phospholipids and glycolipids, which are essential components of nerve cell membranes and the myelin sheath. During nerve injury or degeneration, the demand for these substrates increases; Keltican Forte aims to provide these precursors to facilitate axonal and myelin repair. Vitamin B12 and folic acid are included as essential cofactors that support cell division, DNA synthesis, and the overall maintenance of nervous system function. It is commonly utilized in the management of conditions such as spinal syndromes (sciatica, herniated discs), neuralgias, and various forms of polyneuropathy.

Brand names
Keltican Forte
Other names
KelticanKeltican forte
02

Targets

MTR (Methionine synthase)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on Keltican Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keltican Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call